MetLife, Inc.
MET
$79.51
-$2.24-2.74%
NYSE
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 4.29B | 4.50B | 4.43B | 3.76B | 2.91B |
| Total Depreciation and Amortization | 712.00M | 714.00M | 714.00M | 725.00M | 719.00M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 8.86B | 9.95B | 8.09B | 9.23B | 9.40B |
| Change in Net Operating Assets | 1.37B | 1.37B | 1.37B | 1.45B | 1.45B |
| Cash from Operations | 15.23B | 16.53B | 14.60B | 15.17B | 14.48B |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -13.83B | -12.19B | -11.49B | -5.55B | -6.36B |
| Cash from Investing | -13.83B | -12.19B | -11.49B | -5.55B | -6.36B |
| Total Debt Issued | 2.15B | 2.39B | 1.85B | 2.02B | 3.14B |
| Total Debt Repaid | -2.22B | -3.43B | -3.08B | -3.32B | -3.79B |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -3.10B | -3.45B | -3.21B | -3.66B | -3.68B |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -1.71B | -1.72B | -1.73B | -1.74B | -1.75B |
| Other Financing Activities | 4.89B | 3.56B | 3.03B | 3.91B | 3.58B |
| Cash from Financing | 4.00M | -2.65B | -3.13B | -2.79B | -2.49B |
| Foreign Exchange rate Adjustments | -12.00M | -208.00M | -545.00M | 25.00M | -253.00M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1.39B | 1.49B | -571.00M | 6.85B | 5.37B |